Search Results - "Ilyinskii, Petr O."

Refine Results
  1. 1

    Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles by Ilyinskii, Petr O, Roy, Christopher J, LePrevost, Julie, Rizzo, Gina L, Kishimoto, Takashi Kei

    Published in Frontiers in immunology (25-05-2021)
    “…ImmTOR biodegradable nanoparticles encapsulating rapamycin have been shown to induce a durable tolerogenic immune response to co-administered biologics and…”
    Get full text
    Journal Article
  2. 2

    Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism by Vyshedskiy, Andrey, Khokhlovich, Edward, Dunn, Rita, Faisman, Alexander, Elgart, Jonah, Lokshina, Lisa, Gankin, Yuriy, Ostrovsky, Simone, deTorres, Lauren, Edelson, Stephen M, Ilyinskii, Petr O

    Published in Healthcare (Basel) (16-12-2020)
    “…Prefrontal synthesis (PFS) is defined as the ability to juxtapose mental visuospatial objects at will. Paralysis of PFS may be responsible for the lack of…”
    Get full text
    Journal Article
  3. 3

    Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy by Ilyinskii, Petr O, Kovalev, Grigoriy I, O'Neil, Conlin P, Roy, Christopher J, Michaud, Alicia M, Drefs, Natalia M, Pechenkin, Mikhail A, Fu, Fen-Ni, Johnston, Lloyd P M, Ovchinnikov, Dmitry A, Kishimoto, Takashi Kei

    Published in PloS one (01-06-2018)
    “…We previously reported that synthetic vaccine particles (SVP) encapsulating antigens and TLR agonists resulted in augmentation of immune responses with minimal…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Toxicity of Influenza A Virus Matrix Protein 2 for Mammalian Cells is Associated with its Intrinsic Proton-Channeling Activity by Ilyinskii, Petr O., Gabai, Vladimir L., Sunyaev, Shamil R., Thoidis, Galini, Shneider, Alexander M.

    Published in Cell cycle (Georgetown, Tex.) (15-08-2007)
    “…Molecules of influenza matrix protein 2 (M2) are organized in tetramers that constitute a well-conserved virion component and also form proton channels in the…”
    Get full text
    Journal Article
  6. 6

    CD1d Mediates T-Cell-Dependent Resistance to Secondary Infection with Encephalomyocarditis Virus (EMCV) In Vitro and Immune Response to EMCV Infection In Vivo by ILYINSKII, Petr O, WANE, Ruojie, BALK, Steven P, EXLEY, Mark A

    Published in Journal of Virology (01-07-2006)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency by Ilyinskii, Petr O, Gambaryan, Alexandra S, Meriin, Anatoli B, Gabai, Vladimir, Kartashov, Alex, Thoidis, Galini, Shneider, Alexander M

    Published in PloS one (16-01-2008)
    “…The effectiveness of recombinant vaccines encoding full-length M2 protein of influenza virus or its ectodomain (M2e) have previously been tested in a number of…”
    Get full text
    Journal Article
  10. 10

    Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents by Ilyinskii, Petr O, Roy, Christopher, Michaud, Alicia, Rizzo, Gina, Capela, Teresa, Leung, Sheldon S, Kishimoto, Takashi Kei

    Published in PNAS nexus (01-11-2023)
    “…Abstract Tolerogenic ImmTOR nanoparticles encapsulating rapamycin have been demonstrated to mitigate immunogenicity of adeno-associated virus (AAV) gene…”
    Get full text
    Journal Article
  11. 11

    Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles by Ilyinskii, Petr O, Michaud, Alicia M, Roy, Christopher J, Rizzo, Gina L, Elkins, Stephanie L, Capela, Teresa, Chowdhury, Aparajita C, Leung, Sheldon S, Kishimoto, Takashi K

    Published in Science advances (01-02-2021)
    “…Systemic AAV (adeno-associated virus) gene therapy is a promising approach for the treatment of inborn errors of metabolism, but questions remain regarding its…”
    Get full text
    Journal Article
  12. 12

    Development of a Vaccine Against Pandemic Influenza Viruses: Current Status and Perspectives by Ilyinskii, Petr O., Thoidis, Galini, Shneider, Alexander M.

    Published in International reviews of immunology (01-01-2008)
    “…The constant threat of a new influenza pandemic, which may be caused by a highly pathogenic avian influenza virus, necessitates the development of a vaccine…”
    Get full text
    Journal Article
  13. 13

    Importance of mRNA secondary structural elements for the expression of influenza virus genes by Ilyinskii, Petr O, Schmidt, Thorsten, Lukashev, Dmitry, Meriin, Anatoli B, Thoidis, Galini, Frishman, Dmitrij, Shneider, Alexander M

    Published in Omics (Larchmont, N.Y.) (01-10-2009)
    “…Development of novel vaccines and therapeutics often requires efficient expression of recombinant viral proteins. Here we show that mutations in essential…”
    Get more information
    Journal Article
  14. 14

    The proteosomal degradation of fusion proteins cannot be predicted from the proteosome susceptibility of their individual components by Ilyinskii, Petr O., Meriin, Anatoli B., Gabai, Vladimir L., Usachev, Evgeny V., Prilipov, Alexei G., Thoidis, Galini, Shneider, Alexander M.

    Published in Protein science (01-06-2008)
    “…It is assumed that the proteosome‐processing characteristics of fusion constructs can be predicted from the sum of the proteosome sensitivity of their…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effective expression of recombinant cytotoxic protein via its attachment to a polyglutamine domain by Ilyinskii, Petr O, Nurminskaya, Maria V, Gabai, Vladimir L, Prilipov, Alexei G, Usachev, Evgeny V, Zakharova, Lyudmila G, Thoidis, Galini, Altstein, Anatoly D, Shneider, Alexander M

    Published in Omics (Larchmont, N.Y.) (01-06-2009)
    “…Inadvertent cytotoxicity may hinder the expression of many recombinant proteins that are of industrial or medicinal importance. Here, we show that covalent…”
    Get more information
    Journal Article
  17. 17

    Association of Simian Virus 40 with a Central Nervous System Lesion Distinct from Progressive Multifocal Leukoencephalopathy in Macaques with AIDS by Simon, Meredith A., Ilyinskii, Petr O., Baskin, Gary B., Knight, Heather Y., Pauley, Douglas R., Lackner, Andrew A.

    Published in The American journal of pathology (01-02-1999)
    “…The primate polyomavirus SV40 is known to cause interstitial nephritis in primary infections and progressive multifocal leukoencephalopathy (PML) upon…”
    Get full text
    Journal Article
  18. 18

    Sequences Just Upstream of the Simian Immunodeficiency Virus Core Enhancer Allow Efficient Replication in the Absence of NF-κB and Sp1 Binding Elements by Pöhlmann, Stefan, Flöss, Stefan, Ilyinskii, Petr O., Stamminger, Thomas, Kirchhoff, Frank

    Published in Journal of Virology (01-07-1998)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  19. 19

    A malignant astrocytoma containing simian virus 40 DNA in a macaque infected with simian immunodeficiency virus by Hurley, John P., Ilyinskii, Petr O., Horvath, Christopher J., Simon, Meredith A.

    Published in Journal of medical primatology (01-06-1997)
    “…: Polyomaviruses have proven oncogenicity in nonhost experimental animals; however, studies concerning the association between human brain tumors and simian…”
    Get full text
    Journal Article
  20. 20

    Identification of a nef allele that causes lymphocyte activation and acute disease in Macaque monkeys by Du, Zhenjian, Lang, Sabine M., Sasseville, Vito G., Lackner, Andrew A., Ilyinskii, Petr O., Daniel, Muthiah D., Jung, Jae U., Desrosiers, Ronald C.

    Published in Cell (25-08-1995)
    “…Residues 17 and 18 In nef of SIVmac239 were changed from RQ to YE to create a translated sequence of SRP-SGDLYERLLRARGETYGRLLGEVEDGYSOSP from residues 10–43…”
    Get full text
    Journal Article